Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients

International Journal of Cardiology

Volumn 179, Issue , 2015, Pages 139-143

  Perri, Ludovica ^a   Pastori, Daniele ^a   Pignatelli, Pasquale ^a   Violi, Francesco ^a   Loffredo, Lorenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atrial fibrillation; Endothelial dysfunction; Flow mediated diolation; Myocardial infarction

Indexed keywords

ACENOCOUMAROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL RATE; TRENDS; VASODILATATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE; VASODILATION;

EID: 84920641606     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.10.039     Document Type: Article

References (43)

1. V. Fuster Atrial fibrillation: an epidemiologic, scientific and clinical challenge Nat. Clin. Pract. Cardiovasc. Med. 2 2005 225
2. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
3. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
4. H.J. Lin, P.A. Wolf, M. Kelly-Hayes, A.S. Beiser, C.S. Kase, and E.J. Benjamin Stroke severity in atrial fibrillation. The Framingham study Stroke 27 1996 1760 1764
5. F. Violi, and L. Loffredo Thromboembolism or atherothromboembolism in atrial fibrillation? Circ. Arrhythm. Electrophysiol. 5 2012 1053 1055
6. J. Heeringa, D.A. van der Kuip, A. Hofman, J.A. Kors, F.J. van Rooij, and G.Y. Lip Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam study Arch. Intern. Med. 167 2007 382 387
7. H. Watanabe, N. Tanabe, T. Watanabe, D. Darbar, D.M. Roden, and S. Sasaki Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study Circulation 117 2008 1255 1260
8. E.Z. Soliman, M.M. Safford, P. Muntner, Y. Khodneva, F.Z. Dawood, and N.A. Zakai Atrial fibrillation and the risk of myocardial infarction JAMA Intern. Med. 174 2014 107 114
9. L. Polimeni, L. Perri, M. Saliola, S. Basili, and F. Violi The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue Intern. Emerg. Med. 5 2010 91 94
10. J.A. Vita, and J.F. Keaney Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 106 2002 640 642
11. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115 126
12. J.T. Kuvin, and R.H. Karas Clinical utility of endothelial function testing: ready for prime time? Circulation 107 2003 3243 3247
13. M. Al-Qaisi, R.K. Kharbanda, T.K. Mittal, and A.E. Donald Measurement of endothelial function and its clinical utility for cardiovascular risk Vasc. Health Risk Manag. 4 2008 647 652
14. M.L. Muiesan, M. Salvetti, A. Paini, C. Monteduro, G. Galbassini, and P. Poisa Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients J. Hypertens. 26 2008 1612 1618
15. G. Brevetti, A. Silvestro, V. Schiano, and M. Chiariello Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index Circulation 108 2003 2093 2098
16. S.D. Katz, K. Hryniewicz, I. Hriljac, K. Balidemaj, C. Dimayuga, and A. Hudaihed Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure Circulation 111 2005 310 314
17. N. Gokce, J.F. Keaney Jr., L.M. Hunter, M.T. Watkins, Z.S. Nedeljkovic, and J.O. Menzoian Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J. Am. Coll. Cardiol. 41 2003 1769 1775
18. Y. Inaba, J.A. Chen, and S.R. Bergmann Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis Int. J. Cardiovasc. Imaging 26 2010 631 640
19. Y. Matsue, M. Suzuki, M. Abe, M. Ono, M. Seya, and T. Nakamura Endothelial dysfunction in paroxysmal atrial fibrillation as a prothrombotic state. Comparison with permanent/persistent atrial fibrillation J. Atheroscler. Thromb. 18 2011 298 304
20. C.X. Wong, H.S. Lim, C.D. Schultz, P. Sanders, M.I. Worthley, and S.R. Willoughby Assessment of endothelial function in atrial fibrillation: utility of peripheral arterial tonometry Clin. Exp. Pharmacol. Physiol. 39 2012 141 144
21. A.M. Chamberlain, S.K. Agarwal, M. Ambrose, A.R. Folsom, E.Z. Soliman, and A. Alonso Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study Am. Heart J. 159 2010 850 856
22. E.I. Skalidis, E.A. Zacharis, D.K. Tsetis, K. Pagonidis, G. Chlouverakis, and S. Yarmenitis Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm Am. J. Cardiol. 99 2007 1258 1262
23. European Heart Rhythm A, European Association for Cardio-Thoracic S, A.J. Camm, P. Kirchhof, G.Y. Lip, and U. Schotten Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur. Heart J. 31 2010 2369 2429
24. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J. 28 2007 1462 1536
25. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet. Med. 15 1998 539 553
26. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J. 29 2008 2388 2442
27. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, and M.A. Creager Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J. Am. Coll. Cardiol. 39 2002 257 265
28. L. Loffredo, A. Marcoccia, P. Pignatelli, P. Andreozzi, M.C. Borgia, and R. Cangemi Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease Eur. Heart J. 28 2007 608 612
29. B. Freestone, A.Y. Chong, S. Nuttall, and G.Y. Lip Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels Thromb. Res. 122 2008 85 90
30. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, and H.D. White Third universal definition of myocardial infarction J. Am. Coll. Cardiol. 60 2012 1581 1598
31. Special report from the National Institute of Neurological Disorders and Stroke Classification of cerebrovascular diseases III Stroke 21 1990 637 676
32. World Medical A World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects Bull. World Health Organ. 79 2001 373 374
33. M. Shechter, A. Shechter, N. Koren-Morag, M.S. Feinberg, and L. Hiersch Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease Am. J. Cardiol. 113 2014 162 167
34. T. Maruhashi, J. Soga, N. Fujimura, N. Idei, S. Mikami, and Y. Iwamoto Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study Heart 99 2013 1837 1842
35. D.M. Herrington, L. Fan, M. Drum, W.A. Riley, B.E. Pusser, and J.R. Crouse Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter J. Cardiovasc. Risk 8 2001 319 328
36. D.S. Celermajer, K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, and I.D. Sullivan Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
37. S.D. Weiner, H.N. Ahmed, Z. Jin, M. Cushman, D.M. Herrington, and J.C. Nelson Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA) Heart 100 2014 862 866
38. J. Yeboah, J.R. Crouse, F.C. Hsu, G.L. Burke, and D.M. Herrington Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study Circulation 115 2007 2390 2397
39. M.L. Bots, J. Westerink, T.J. Rabelink, and E.J. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur. Heart J. 26 2005 363 368
40. K.L. Hardie, S. Kinlay, D.B. Hardy, J. Wlodarczyk, J.S. Silberberg, and P.J. Fletcher Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial function Aust. NZ J. Med. 27 1997 649 652
41. P. Hamilton, C.J. Lockhart, A.J. McCann, C.E. Agnew, M.T. Harbinson, and V. McClenaghan Flow-mediated dilatation of the brachial artery is a poorly reproducible indicator of microvascular function in Type I diabetes mellitus QJM 104 2011 589 597
42. I.I. Simova, R.R. Todorova-Konstantinova, and S.V. Denchev Effects of nebivolol versus bisoprolol on endothelial function in hypertensive patients Exp. Clin. Cardiol. 14 2009 45 49
43. R. Nerla, A. Di Franco, M. Milo, D. Pitocco, F. Zaccardi, and P. Tarzia Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients Heart 98 2012 1812 1816